FATE THERAPEUTICS INC

FATE Nasdaq CIK: 0001434316

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
Business Address 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
Mailing Address 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
Phone 858.875.1803
Fiscal Year End 1231
EIN 651311552

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
10-K Annual financial report February 26, 2026 View on SEC
8-K Current report of material events February 26, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 12, 2026 View on SEC
4 Insider stock transaction report January 12, 2026 View on SEC
8-K Current report of material events November 13, 2025 View on SEC
10-Q Quarterly financial report November 13, 2025 View on SEC

Insider Trading

SELL 2 insiders 2 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.